2026年9月24日星期四
M
Всеобъемлющее обозрение
Глобальные новости
Talent shortage emerges as tech's biggest bottleneck in AI expansion boom— 日经 Nikkei AsiaJapan's JFE Engineering, startups bet on Philippine renewable energy— 日经 Nikkei AsiaTaiwan's ruling DPP rethinks nuclear power opposition in AI era— 日经 Nikkei AsiaTokyo commercial land prices jump to 33-year high as remote work ebbs— 日经 Nikkei AsiaJapan Air Self-Defense Force confirms Global Hawk drone crash— 日经 Nikkei AsiaJapan trading house lobby chief urges stronger yen despite sector windfall— 日经 Nikkei AsiaUK eyes role in Vietnam infrastructure boom with $2.5bn metro financing— 日经 Nikkei AsiaAustralia's rising far-right leader raises alarm over China's EV influx— 日经 Nikkei AsiaTalent shortage emerges as tech's biggest bottleneck in AI expansion boom— 日经 Nikkei AsiaJapan's JFE Engineering, startups bet on Philippine renewable energy— 日经 Nikkei AsiaTaiwan's ruling DPP rethinks nuclear power opposition in AI era— 日经 Nikkei AsiaTokyo commercial land prices jump to 33-year high as remote work ebbs— 日经 Nikkei AsiaJapan Air Self-Defense Force confirms Global Hawk drone crash— 日经 Nikkei AsiaJapan trading house lobby chief urges stronger yen despite sector windfall— 日经 Nikkei AsiaUK eyes role in Vietnam infrastructure boom with $2.5bn metro financing— 日经 Nikkei AsiaAustralia's rising far-right leader raises alarm over China's EV influx— 日经 Nikkei Asia

Nicotine pharmacokinetics and abuse liability of commercially available tobacco products: an open-label, randomized, controlled study

Источник Nature 医学研究8 дней назад
Аннотация

Nicotine pharmacokinetics and abuse liability of commercially available tobacco products: an open-label, randomized, controlled study

Сайт предоставляет только заголовки и индексы аннотаций; полный контент и авторские права принадлежат первоисточнику. Для чтения перейдите по ссылке на оригинал.

Перейти к оригиналу
Канал
Здоровье
Регион
Глобальный взгляд
Язык оригинала
English
Номер записи
health-fbb71fa9

Comments 0 comments

No comments yet. Be the first.

Nicotine pharmacokinetics and abuse liability of commercially available tobacco products: an open-label, randomized, controlled study · Всеобъемлющее обозрение